about
Solution and Solid-State Analysis of Binding of 13-Substituted Berberine Analogues to Human Telomeric G-quadruplexesSIRT6 interacts with TRF2 and promotes its degradation in response to DNA damage.The topoisomerase II catalytic inhibitor ICRF-193 preferentially targets telomeres that are capped by TRF2.Clinical Relevance of Telomere Status and Telomerase Activity in Colorectal Cancer.Predicting chemotherapeutic drug combinations through gene network profilingImpact of chemotherapy on telomere length in sporadic and familial breast cancer patients.Disease drivers of aging.The Effect of Cancer Treatments on Telomere Length: A Systematic Review of the Literature
P2860
Q27704001-AF66F902-5B59-44DF-9D9C-571F63603A3EQ33558275-0EE98D2B-0FAF-4883-8F84-490C3B0BF51EQ35527683-2A67BD72-2358-4C03-A334-CADBAEBFD589Q35935417-60B5C823-F523-4AB0-942E-20D363B4D2FFQ36500982-BFBF41B7-9AA2-47E1-9873-D5B96321A2F7Q36776304-6FD7DAE2-12C0-4F7B-83E2-6BD31A70A0CAQ37730342-65A138D5-3A46-4923-AA5B-1FF0D575835BQ57067048-C93A95E0-A17F-47AD-874B-7F7F51DB6CA2
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Telomeric impact of conventional chemotherapy.
@en
type
label
Telomeric impact of conventional chemotherapy.
@en
prefLabel
Telomeric impact of conventional chemotherapy.
@en
P2093
P2860
P1476
Telomeric impact of conventional chemotherapy.
@en
P2093
Eric Gilson
Olivier Guérin
Waiian Leong
P2860
P2888
P304
P356
10.1007/S11684-013-0293-Z
P577
2013-10-23T00:00:00Z
P6179
1048267601